Insider Trading activities of Angiotech Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Angiotech Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Angiotech Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Angiotech Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is ANPI. The reporting company's CIK number is 1096481.
The total value of stock buying since 2005 is $4,670,201.
The total value of stock sales since 2005 is $17,658,574.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Angiotech Pharmaceuticals Inc (ANPI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2012-06 0 $0 1,115,000 $17,204,450 0 $0
2010-03 9,000 $9,990 0 $0 0 $0
2009-11 15,600 $21,684 0 $0 0 $0
2009-09 49,500 $93,951 0 $0 0 $0
2009-08 98,600 $178,531 0 $0 0 $0
2009-06 32,500 $58,525 0 $0 0 $0
2009-05 640,051 $372,320 0 $0 0 $0
2009-03 214,040 $71,064 0 $0 0 $0
2008-12 5,573,322 $924,284 2,398,788 $397,487 0 $0
2008-11 625,000 $96,767 0 $0 0 $0
2008-10 160,000 $55,519 155,300 $56,637 0 $0
2008-03 1,155,276 $1,973,498 0 $0 0 $0
2008-02 255,194 $814,068 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Angiotech Pharmaceuticals Inc insiders (ANPI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-06-21 Highland Crusader Offshore Partners, L.p. (10% Owner) Sale 1,115,000 15.43 17,204,450
2010-03-26 Gross Jeffrey M (SVP, Research & Development) Buy 9,000 1.11 9,990
2009-11-20 Hunter William L (President & CEO) Buy 15,600 1.39 21,684
2009-09-29 Hunter William L (President and CEO) Buy 49,500 1.90 93,951
2009-08-27 Gross Jeffrey M (SVP, Research & Development) Buy 6,000 1.68 10,080
2009-08-18 Bailey K Thomas (Chief Financial Officer) Buy 15,000 1.70 25,425
2009-08-17 Bailey K Thomas (Chief Financial Officer) Buy 15,000 1.64 24,600
2009-08-14 Gross Jeffrey M (SVP, Research & Development) Buy 1,500 1.72 2,580
2009-08-14 Neske Tammy (SVP, Human Resources) Buy 6,300 1.90 12,001
2009-08-13 Gross Jeffrey M (SVP, Research & Development) Buy 2,000 1.80 3,600
2009-08-13 Dent Jay Bernard (SVP, Finance) Buy 16,700 1.95 32,565
2009-08-12 Chen Jonathan W (SVP, Business Development) Buy 11,100 1.77 19,680
2009-08-12 Willms Arthur H (Director) Buy 25,000 1.92 48,000
2009-06-22 Gross Jeffrey M (SVP, Research and Development) Buy 20,000 1.77 35,400
2009-06-17 Gross Jeffrey M (SVP, Research & Development) Buy 12,500 1.85 23,125
2009-05-13 Neske Tammy (SVP, Human Resources) Buy 5,500 1.35 7,425
2009-05-05 Hunter William L (President & CEO) Buy 157,738 .56 87,702
2009-05-04 Hunter William L (President & CEO) Buy 32,143 .60 19,285
2009-05-01 Hunter William L (President & CEO) Buy 444,670 .58 257,908
2009-03-18 Hunter William L (President & CEO) Buy 30,500 .40 12,291
2009-03-17 Hunter William L (President & CEO) Buy 53,000 .35 18,550
2009-03-16 Hunter William L (President and CEO) Buy 40,848 .32 12,867
2009-03-13 Hunter William L (President and CEO) Buy 89,692 .30 27,356
2008-12-23 Hunter William L (President and CEO) Buy 33,000 .19 6,237
2008-12-22 Hunter William L (President and CEO) Buy 737,000 .16 116,116
2008-12-19 Hunter William L (President and CEO) Buy 901,513 .17 154,158
2008-12-18 Hunter William L (President and CEO) Buy 223,631 .17 37,122
2008-12-17 Hunter William L (President and CEO) Buy 372,011 .16 58,986
2008-12-16 Orfalea Paul J (10% Owner) Buy 79,400 .15 11,592
2008-12-16 Orfalea Paul J (10% Owner) Sale 494,758 .15 74,708
2008-12-15 Hunter William L (President and CEO) Buy 1,396,748 .17 240,240
2008-12-15 Orfalea Paul J (10% Owner) Sale 1,451,159 .17 246,697
2008-12-12 Hunter William L (President and CEO) Buy 263,241 .16 43,434
2008-12-12 Orfalea Paul J (10% Owner) Sale 201,769 .17 33,897
2008-12-11 Hunter William L (President and CEO) Buy 163,000 .17 28,035
2008-12-11 Orfalea Paul J (10% Owner) Sale 251,102 .17 42,185
2008-12-10 Hunter William L (President and CEO) Buy 102,000 .17 17,748
2008-12-09 Hunter William L (President and CEO) Buy 375,000 .17 65,249
2008-11-27 Richardson Hartley T (Director) Buy 209,500 .17 35,615
2008-11-26 Richardson Hartley T (Director) Buy 65,500 .16 10,152
2008-11-25 Richardson Hartley T (Director) Buy 300,000 .14 42,000
2008-11-19 Howard David T (Director) Buy 50,000 .18 9,000
2008-10-20 Orfalea Paul J (10% Owner) Buy 160,000 .35 55,519
2008-10-20 Orfalea Paul J (10% Owner) Sale 111,400 .35 38,990
2008-10-16 Orfalea Paul J (10% Owner) Sale 43,900 .40 17,647
2008-03-31 Orfalea Paul J (10% Owner) Buy 40,550 1.99 80,694
2008-03-19 Orfalea Paul J (10% Owner) Buy 1,114,726 1.70 1,892,804
2008-02-25 Orfalea Paul J (10% Owner) Buy 255,194 3.19 814,068

Insider trading activities including stock purchases, stock sales, and option exercises of ANPI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Angiotech Pharmaceuticals Inc (symbol ANPI, CIK number 1096481) see the Securities and Exchange Commission (SEC) website.